Monday, December 23, 2024
HomeTagsHummingbird

Hummingbird

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics